HEALTH ALERT! If you have any of the following, please call our office before coming in for your appointment: Fever AND cough; Fever OR cough and recent travel (domestic or international to any destination); Recent international travel to areas impacted by the Coronavirus (2019-nCoV) within the last 14 days; OR close contact with someone who has traveled outside the US or been exposed to the Coronavirus.

We are also limiting the numbers of caregivers that may attend visits at our Practice. Please click the More info link below to get detailed information on recent changes made to ensure the safety of our patients and employees. More Info

For any additional information, please be encouraged to refer to the CDC guidelines and the Virginia Department of Health for up to date information, and to answer further questions that you may have.

https://www.cdc.gov/coronavirus/2019-ncov/index.html
https://www.vdh.virginia.gov/coronavirus

Treatments & Services

Targeted Therapy

Targeted therapies are drugs or other agents that block the growth and spread of cancer by interfering with specific genes or molecules involved in tumor growth and progression.

Genomic sequencing refers to the analysis of the DNA “blueprint” within a specific individual’s cancer, seeking clues as to what is driving the malignancy at its most basic and fundamental level.  Because scientists often refer to these as “molecular targets," such cancer treatments are sometimes referred to as “molecularly targeted drugs/therapies.”  By focusing on molecular and cellular changes that are unique to each cancer, targeted cancer therapies are often less harmful to normal cells and more effective against the cancer than other types of treatment.  

Our physicians routinely test for specific mutations and other traits unique to your cancer that can reveal the best treatment options for you.  However, targeted therapy is not an option every patient or every type of cancer or blood disease.  However, increasing numbers of patients are benefiting from these powerful tools through clinical trial participation or as these agents become available for general use.

Learn More